Bacteriology and Comorbidities in Patients Requiring Surgical Management of Empyema

Concern over the changing bacteriology of empyema has led to numerous attempts to characterize the most common locoregional bacterial isolates. The purpose of this study is to better characterize the bacteriology and demographics in patients with community-acquired pneumonia (CAP) and hospital-acquired pneumonia requiring surgery for empyema. All patients diagnosed with empyema preoperatively and had either a video-assisted thoracoscopic or open decortication surgery from January 2010 to September 2015 were reviewed. Forty-seven patients were identified with a mean age of 54.7 ± 16.8 years (X ± SD). Sixty per cent of patients had CAP. Anaerobes were the most common isolate at 21 per cent, followed by Streptococcus species and Staphylococcus aureus (50% Methicillin Resistant). Coagulase-negative Staphylococcus species were the next most frequent at 13 per cent. Hospital-acquired pneumonia patients had a higher incidence of S. aureus infections (P = 0.047). Cancer history had higher rates of both fungal (P = 0.004) and gram-negative infections (P = 0.03). Older patients had increased incidence of gram-negative infections (P = 0.05). The median length of stay for CAP patient who were intravenous drug abusers (n = 3) were 31 days (95% confidence interval (CI) [15, NA]), which was significantly longer than the others (median 12 days, 95% CI: [9, 18], P = 0.014). Streptococcus pneumoniae was not found in any of the isolates. Our data reveal that anaerobes and Staphylococcus species have replaced S. pneumoniae as the major regional pathogens in surgically treated empyema. In addition, anaerobic isolates were found in higher incidence in CAP than previously reported.

[1]  G. Thommi,et al.  A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions. , 2012, Respiratory medicine.

[2]  N. Solymosi,et al.  Surgical management of pleural empyema in the very elderly , 2012, Annals of the Royal College of Surgeons of England.

[3]  J. M. Porcel,et al.  Predictive factors, microbiology and outcome of patients with parapneumonic effusion , 2011, European Respiratory Journal.

[4]  T. Lisboa,et al.  Pleural infection: Changing bacteriology and its implications , 2011, Respirology.

[5]  A. Friis-Møller,et al.  Bacteriological aetiology and antimicrobial treatment of pleural empyema , 2011, Scandinavian journal of infectious diseases.

[6]  Sara E Cosgrove,et al.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  R. Davies,et al.  Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010 , 2010, Thorax.

[8]  D. Harpole,et al.  Outcomes of video-assisted thoracoscopic decortication. , 2010, The Annals of thoracic surgery.

[9]  C. Tu,et al.  Hospital-Acquired Thoracic Empyema in Adults: A 5-Year Study , 2009, Southern medical journal.

[10]  A. Hill,et al.  Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia , 2009, Thorax.

[11]  C. Byington,et al.  Parapneumonic Empyema Deaths during Past Century, Utah , 2009, Emerging infectious diseases.

[12]  D. Flum,et al.  Management of pleural space infections: a population-based analysis. , 2007, The Journal of thoracic and cardiovascular surgery.

[13]  T. Marrie,et al.  Thoracic empyema in patients with community-acquired pneumonia. , 2006, The American journal of medicine.

[14]  R. Davies,et al.  The bacteriology of pleural infection by genetic and standard methods and its mortality significance. , 2006, American journal of respiratory and critical care medicine.

[15]  P. Wurnig,et al.  Video-assisted thoracic surgery for pleural empyema. , 2006, The Annals of thoracic surgery.

[16]  C. Tu,et al.  The changing pathogens of complicated parapneumonic effusions or empyemas in a medical intensive care unit , 2006, Intensive Care Medicine.

[17]  M. Kollef,et al.  Pleuropulmonary complications of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus: importance of treatment with antimicrobials inhibiting exotoxin production. , 2005, Chest.

[18]  R. Davies,et al.  U.K. Controlled trial of intrapleural streptokinase for pleural infection. , 2005, The New England journal of medicine.

[19]  D. Musher,et al.  Surgical versus Nonsurgical Treatment of Empyema Thoracis: An Outcomes Analysis , 2003, The American journal of the medical sciences.

[20]  B. Littenberg,et al.  Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline. , 2000, Chest.

[21]  P. Hsueh,et al.  A 10-year experience with bacteriology of acute thoracic empyema: emphasis on Klebsiella pneumoniae in patients with diabetes mellitus. , 2000, Chest.

[22]  F. Gleeson,et al.  Predictors of outcome and long-term survival in patients with pleural infection. , 1999, American journal of respiratory and critical care medicine.

[23]  J. Kolbe,et al.  Community acquired parapneumonic thoracic empyema: Predictors of outcome , 1999, Respirology.

[24]  P. Hsueh,et al.  Empyema thoracis and lung abscess caused by viridans streptococci. , 1997, American journal of respiratory and critical care medicine.

[25]  M. Wait,et al.  A randomized trial of empyema therapy. , 1997, Chest.

[26]  J. Macfarlane,et al.  Streptococcus milleri pulmonary disease: a review and clinical description of 25 patients. , 1995, Thorax.

[27]  H. Shah,et al.  A retrospective review of cases of anaerobic empyema and update of bacteriology. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  S. Sahn Management of complicated parapneumonic effusions. , 1993, The American review of respiratory disease.

[29]  I. Alfageme,et al.  Empyema of the thorax in adults. Etiology, microbiologic findings, and management. , 1993, Chest.

[30]  J. Smith,et al.  Empyema thoracis: 14-year experience in a teaching center. , 1991, The Annals of thoracic surgery.

[31]  P. Mayo Early thoracotomy and decortication for nontuberculous empyema in adults with and without underlying disease. A twenty-five year review. , 1985, The American surgeon.

[32]  B. Varkey,et al.  Empyema thoracis during a ten-year period. Analysis of 72 cases and comparison to a previous study (1952 to 1967). , 1981, Archives of internal medicine.

[33]  J. Bartlett,et al.  Bacteriology of empyema. , 1974, Lancet.

[34]  N. Vianna Nontuberculous bacterial empyema in patients with and without underlying diseases. , 1971, JAMA.